FDA Approves Merck’s NOXAFIL (posaconazole) Delayed-Release Tablets

27-11-2013 Business Wire HealthComments (0)

Merck & CoNoxafilPharmaceuticalUSA

Merck announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL (posaconazole) 100 mg delayed-release tablet

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top